0001836562-21-000002.txt : 20211008 0001836562-21-000002.hdr.sgml : 20211008 20211008132441 ACCESSION NUMBER: 0001836562-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211008 DATE AS OF CHANGE: 20211008 EFFECTIVENESS DATE: 20211008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hopewell Therapeutics, Inc. CENTRAL INDEX KEY: 0001836562 IRS NUMBER: 823045662 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-416327 FILM NUMBER: 211314791 BUSINESS ADDRESS: STREET 1: 405 WALTHAM STREET CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 921 7082 MAIL ADDRESS: STREET 1: 405 WALTHAM STREET CITY: LEXINGTON STATE: MA ZIP: 02421 D 1 primary_doc.xml X0708 D LIVE 0001836562 Hopewell Therapeutics, Inc. 405 WALTHAM STREET LEXINGTON MA MASSACHUSETTS 02421 617 921 7082 DELAWARE None None Corporation true 2018 Qiaobing Xu 405 Waltham Street, Ste 418 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Thomas V. Hennessey 405 Waltham Street, Ste 418 Lexington MA MASSACHUSETTS 02421 Director Biotechnology Decline to Disclose 06b false 2021-09-24 false true false 0 8007235 8007235 0 false 2 0 0 0 false Hopewell Therapeutics, Inc. Qiaobing Xu Qiaobing Xu Chief Executive Officer 2021-10-08